Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Mar. 31, 2015 | Apr. 30, 2015 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | Enphase Energy, Inc. | |
Entity Central Index Key | 1463101 | |
Document Type | 10-Q | |
Document Period End Date | 31-Mar-15 | |
Amendment Flag | FALSE | |
Document Fiscal Year Focus | 2015 | |
Document Fiscal Period Focus | Q1 | |
Current Fiscal Year End | -19 | |
Entity Filer Category | Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 44,155,790 |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (Unaudited) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Thousands, unless otherwise specified | ||
Current assets: | ||
Cash and cash equivalents | $27,127 | $42,032 |
Accounts receivable, net of allowances of $533 and $569 at March 31, 2015 and December 31, 2014, respectively | 45,870 | 45,119 |
Inventory | 34,746 | 21,590 |
Prepaid expenses and other assets | 7,087 | 6,155 |
Total current assets | 114,830 | 114,896 |
Property and equipment, net | 31,197 | 30,824 |
Goodwill | 3,745 | 3,745 |
Intangibles, net | 1,704 | 1,811 |
Other assets | 2,014 | 916 |
Total assets | 153,490 | 152,192 |
Current liabilities: | ||
Accounts payable | 30,954 | 22,316 |
Accrued liabilities | 20,230 | 26,036 |
Deferred revenues | 3,558 | 2,747 |
Warranty obligations, current portion (includes $1,534 and $1,125 measured at fair value at March 31, 2015 and December 31, 2014, respectively) | 7,550 | 7,607 |
Total current liabilities | 62,292 | 58,706 |
Long-term liabilities: | ||
Deferred revenues, noncurrent | 18,217 | 16,612 |
Warranty obligations, noncurrent (includes $3,249 and $2,437 measured at fair value at March 31, 2015 and December 31, 2014, respectively) | 26,613 | 26,333 |
Other liabilities | 2,387 | 3,589 |
Total liabilities | 109,509 | 105,240 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $0.00001 par value, 10,000 shares authorized; none issued and outstanding | 0 | 0 |
Common stock, $0.00001 par value, 100,000 shares authorized; 44,117 and 43,756 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively | 0 | 0 |
Additional paid-in capital | 211,687 | 208,022 |
Accumulated deficit | -167,311 | -160,991 |
Accumulated other comprehensive loss | -395 | -79 |
Total stockholders’ equity | 43,981 | 46,952 |
Total liabilities and stockholders’ equity | $153,490 | $152,192 |
Condensed_Consolidated_Balance1
Condensed Consolidated Balance Sheets (Unaudited ) (Parenthetical) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Thousands, except Share data, unless otherwise specified | ||
Statement of Financial Position [Abstract] | ||
Allowances, accounts receivable | $533 | $569 |
Warranty obligations, current at fair value | 1,534 | 1,125 |
Warranty obligations, non-current at fair value | $3,249 | $2,437 |
Preferred stock, par value (in usd per share) | $0.00 | $0.00 |
Preferred stock, shares authorized (in shares) | 10,000,000 | 10,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in usd per share) | $0.00 | $0.00 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (in shares) | 44,117,000 | 43,756,000 |
Common stock, shares outstanding (in shares) | 44,117,000 | 43,756,000 |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements of Operations (Unaudited) (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Income Statement [Abstract] | ||
Net revenues | $86,653 | $57,580 |
Cost of revenues | 58,629 | 38,925 |
Gross profit | 28,024 | 18,655 |
Operating expenses: | ||
Research and development | 13,430 | 9,086 |
Sales and marketing | 11,937 | 8,828 |
General and administrative | 8,205 | 6,526 |
Total operating expenses | 33,572 | 24,440 |
Loss from operations | -5,548 | -5,785 |
Other income (expense), net: | ||
Interest expense | -78 | -449 |
Other (expense) income | -527 | 107 |
Total other expense, net | -605 | -342 |
Loss before income taxes | -6,153 | -6,127 |
Provision for income taxes | -167 | -109 |
Net loss | ($6,320) | ($6,236) |
Net loss per share, basic and diluted (in usd per share) | ($0.14) | ($0.15) |
Shares used in computing net loss per share, basic and diluted (in shares) | 43,950 | 42,205 |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Statement of Comprehensive Income [Abstract] | ||
Net loss | ($6,320) | ($6,236) |
Other comprehensive (loss) income: | ||
Foreign currency translation adjustments | -316 | 1 |
Comprehensive loss | ($6,636) | ($6,235) |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Cash flows from operating activities: | ||
Net loss | ($6,320) | ($6,236) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 2,532 | 1,910 |
Provision for doubtful accounts | 0 | 26 |
Net loss on disposal of assets | 191 | 6 |
Non-cash interest expense | 39 | 102 |
Stock-based compensation | 2,988 | 2,013 |
Revaluation of contingent consideration liability | 104 | 0 |
Changes in operating assets and liabilities: | ||
Accounts receivable | -751 | 3,608 |
Inventory | -13,156 | 2,467 |
Prepaid expenses and other assets | -2,069 | -977 |
Accounts payable, accrued and other liabilities | 2,305 | 1,159 |
Warranty obligations | 223 | 296 |
Deferred revenues | 2,416 | -93 |
Net cash (used in) provided by operating activities | -11,498 | 4,281 |
Cash flows from investing activities: | ||
Purchases of property and equipment | -3,611 | -2,172 |
Net cash used in investing activities | -3,611 | -2,172 |
Cash flows from financing activities: | ||
Repayments of term loans | 0 | -866 |
Proceeds from issuance of common stock under employee stock plans | 677 | 454 |
Net cash provided by (used in) financing activities | 677 | -412 |
Effect of exchange rate changes on cash | -473 | 48 |
Net (decrease) increase in cash and cash equivalents | -14,905 | 1,745 |
Cash and cash equivalents—Beginning of period | 42,032 | 38,190 |
Cash and cash equivalents—End of period | 27,127 | 39,935 |
Supplemental disclosures of non-cash investing and financing activities: | ||
Purchases of property and equipment included in accounts payable | $1,269 | $497 |
OVERVIEW_AND_SUMMARY_OF_SIGNIF
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Description of Business | |
Enphase Energy, Inc. and subsidiaries (the “Company”) designs, develops, and sells microinverter systems for the solar photovoltaic industry. The Company was incorporated in 2006 and began selling its products in 2008. The Company’s microinverter system consists of (i) an Enphase microinverter and related accessories that convert direct current (“DC”) power to grid-compliant alternating current (“AC”) power; (ii) an Envoy communications gateway device that collects and transmits performance information from each solar module to the Company’s hosted data center; and (iii) the Enlighten web-based software platform that collects and processes this information to enable customers to monitor and manage their solar power systems. The Company sells microinverter systems primarily to distributors who resell them to solar installers. The Company also sells directly to large installers as well as through original equipment manufacturers (“OEMs”) and strategic partners. The Company also offers operations and maintenance services for photovoltaic (“PV”) systems including preventive and corrective maintenance, solar panel cleaning and solar system commissioning. | |
Basis of Presentation and Consolidation | |
The accompanying condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the U.S, or GAAP. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidation. | |
Unaudited Interim Financial Information | |
These accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, consisting of normal recurring items, considered necessary to present fairly the Company's financial condition, results of operations, comprehensive income (loss) and cash flows for the interim periods indicated. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the operating results for the full year. Certain information and footnote disclosures typically included in annual consolidated financial statements have been condensed or omitted. Accordingly, these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. | |
There have been no material changes in the Company’s significant accounting policies during the three months ended March 31, 2015 as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. Reference is made to the disclosures therein for a summary of all of the Company’s significant accounting policies. | |
Use of Estimates | |
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant estimates and assumptions reflected in the financial statements include revenue recognition, inventory valuation and accrued warranty obligations. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ materially from management’s estimates using different assumptions or under different conditions. | |
Recent Accounting Pronouncements Not Yet Effective | |
In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09 (Topic 606), Revenue from Contracts with Customers, which will replace most existing revenue recognition guidance under US GAAP. The updated standard’s core principle is that revenue is recognized when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The standard generally requires an entity to identify performance obligations in its contracts, estimate the amount of variable consideration to be received in the transaction price, allocate the transaction price to each separate performance obligation, and recognize revenue as obligations are satisfied. In addition, the updated standard requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts. ASU 2014-09 is effective for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted. Accordingly, the ASU will be effective for the Company beginning in the first quarter of 2017. The Company is currently evaluating the impact of the adoption on its consolidated financial statements. |
INVENTORY
INVENTORY | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Inventory Disclosure [Abstract] | ||||||||
INVENTORY | INVENTORY | |||||||
Inventory as of March 31, 2015 and December 31, 2014 consists of the following (in thousands): | ||||||||
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
Raw materials | $ | 4,179 | $ | 3,429 | ||||
Finished goods | 30,567 | 18,161 | ||||||
Total inventory | $ | 34,746 | $ | 21,590 | ||||
WARRANTY_OBLIGATIONS
WARRANTY OBLIGATIONS | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Product Warranties Disclosures [Abstract] | ||||||||
WARRANTY OBLIGATIONS | WARRANTY OBLIGATIONS | |||||||
The Company’s warranty activities during the three months ended March 31, 2015 and 2014 were as follows (in thousands): | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Warranty obligations, beginning of period | $ | 33,940 | $ | 30,432 | ||||
Accruals for warranties issued during period | 1,105 | 613 | ||||||
Changes in estimates | 58 | 1,400 | ||||||
Settlements | (1,151 | ) | (1,733 | ) | ||||
Increase due to accretion expense | 161 | 20 | ||||||
Other | 50 | (4 | ) | |||||
Warranty obligations, end of period | $ | 34,163 | $ | 30,728 | ||||
Less current portion | $ | (7,550 | ) | $ | (5,894 | ) | ||
Noncurrent | $ | 26,613 | $ | 24,834 | ||||
For the three months ended March 31, 2014, warranty expense included net changes in estimates of $1.4 million to reflect higher than originally estimated replacement unit costs related to the Company’s second generation microinverter. | ||||||||
As of March 31, 2015, the $34.2 million in warranty obligations included $4.8 million measured at fair value (see Note 4—Fair Value Measurements). |
FAIR_VALUE_MEASUREMENTS
FAIR VALUE MEASUREMENTS | 3 Months Ended | |||||||||
Mar. 31, 2015 | ||||||||||
Fair Value Disclosures [Abstract] | ||||||||||
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS | |||||||||
The accounting guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. | ||||||||||
The fair value hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset’s or liability’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: | ||||||||||
• | Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company is able to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of such assets or liabilities do not entail a significant degree of judgment. | |||||||||
• | Level 2—Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. | |||||||||
• | Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. | |||||||||
The following table presents the Company’s assets and liabilities that were measured at fair value on a recurring basis and its categorization within the fair value hierarchy at March 31, 2015 and December 31, 2014 (in thousands): | ||||||||||
Fair Value | March 31, | December 31, | ||||||||
Hierarchy | 2015 | 2014 | ||||||||
Assets: | ||||||||||
Foreign currency forward contracts | Level 2 | $ | 59 | $ | 76 | |||||
Liabilities: | ||||||||||
Foreign currency forward contracts | Level 2 | $ | — | $ | — | |||||
Warranty obligations | Level 3 | 4,783 | 3,562 | |||||||
Contingent consideration | Level 3 | 2,404 | 2,300 | |||||||
Derivative Instruments | ||||||||||
The Company utilizes foreign currency forward contracts from time to time to reduce the impact of foreign currency fluctuations arising from both sales and purchases denominated in Euros and the British Pound Sterling. At March 31, 2015 and December 31, 2014, the notional amounts of the Company’s foreign currency forward contracts outstanding were $1.3 million and $1.5 million, respectively. For the three months ended March 31, 2015 and 2014, the Company recorded net gains of $148,000 and $50,000, respectively, related to foreign currency forward contracts in other income (expense), net. | ||||||||||
Fair Value Option for Warranty Obligations Related to Microinverters Sold Since January 1, 2014 | ||||||||||
The Company estimates the fair value of warranty obligations by calculating the warranty obligations in the same manner as for sales prior to January 1, 2014 and applying an expected present value technique to that result. The expected present value technique, an income approach, converts future amounts into a single current discounted amount. In addition to the key estimates of failure rates, claim rates and replacement costs, the Company used certain Level 3 inputs which are unobservable and significant to the overall fair value measurement. Such additional assumptions included a discount rate based on the Company’s credit-adjusted risk-free rate and compensation comprised of a profit element and risk premium required of a market participant to assume the obligation. | ||||||||||
The following table provides information regarding changes in nonfinancial liabilities related to the Company’s warranty obligations measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the periods indicated (in thousands): | ||||||||||
Three Months Ended | ||||||||||
March 31, | ||||||||||
2015 | 2014 | |||||||||
Balance at beginning of period | $ | 3,562 | $ | — | ||||||
Accruals for warranties issued during period | 1,047 | 571 | ||||||||
Changes in estimates | — | — | ||||||||
Settlements | (36 | ) | — | |||||||
Increase due to accretion expense | 161 | 20 | ||||||||
Other | 49 | (4 | ) | |||||||
Balance at end of period | $ | 4,783 | $ | 587 | ||||||
Contingent Consideration Liability | ||||||||||
The contingent consideration liability relates to the Company’s December 2014 acquisition of substantially all of the assets of Next Phase Solar, Inc. (“NPS”). The selling party may be entitled to receive two contingent payments, each based on achievement of defined revenue targets for the two annual periods subsequent to the acquisition date. The range of undiscounted amounts the Company could be required to pay for each contingent payment is between zero and $2.8 million. The amounts are payable, if at all, in early 2016 and 2017 based on achievement of defined 2015 and 2016 revenue targets, respectively. | ||||||||||
The Company is required to reevaluate the fair value of the contingent consideration liability at each reporting period based on new developments and record changes in fair value until such consideration is satisfied through payment upon the achievement of the specified revenue targets or is no longer payable due to failure to achieve the specified revenue targets. The fair value of the contingent consideration liability was estimated by applying the income approach. That measure is based on significant Level 3 inputs not observable in the market. Key assumptions include (i) probability adjusted level of revenues and the resultant payout; and (ii) a risk-adjusted discount rate was estimated using a capital asset pricing model, which reflects an expected rate of return required by a market participant holding a financial instrument with risk attributes similar to the Company’s contingent consideration liability. | ||||||||||
The following table provides information regarding changes in financial liabilities related to the contingent consideration liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2015 (in thousands): | ||||||||||
Balance—December 31, 2014 | $ | 2,300 | ||||||||
Revaluations | 104 | |||||||||
Balance—March 31, 2015 | $ | 2,404 | ||||||||
The increase in fair value of the contingent consideration liability for the three months ended March 31, 2015 was attributed to the shorter discount period between the current balance sheet date and the contingent payment due dates. | ||||||||||
Quantitative and Qualitative Information about Level 3 Fair Value Measurements | ||||||||||
As of March 31, 2015, the significant unobservable inputs used in the fair value measurement of the Company’s liabilities designated as Level 3 are as follows: | ||||||||||
Item Measured at Fair Value | Valuation Technique | Description of Significant Unobservable Input | Percent Used | |||||||
(Weighted-Average) | ||||||||||
Warranty obligations for microinverters sold since January 1, 2014 | Discounted cash flows | Profit element and risk premium | 17% | |||||||
Credit-adjusted risk-free rate | 18% | |||||||||
Contingent consideration liability | Probability-weighted discounted cash flows | Risk-adjusted discount rate | 18% | |||||||
Sensitivity of Level 3 Inputs | ||||||||||
Warranty Obligations | ||||||||||
Each of the significant unobservable inputs is independent of the other. The profit element and risk premium are estimated based on requirements of a third-party participant willing to assume the Company’s warranty obligations. The discount rate is determined by reference to the Company’s own credit standing at the fair value measurement date. Increasing or decreasing the profit element and risk premium input by 100 basis points would not have a material impact on the fair value measurement of the liability. Increasing the discount rate by 100 basis points would result in a $0.2 million reduction of the liability. Decreasing the discount rate by 100 basis points would result in a $0.2 million increase to the liability. | ||||||||||
Contingent Consideration Liability | ||||||||||
Changes in assumed probability adjustments with respect to achievement of target metric can materially impact the fair value measurement of contingent consideration as of the acquisition date and for each subsequent period. Assumptions about the probability and amount of payout will require less subjectivity over the course of the earnout period as management refines estimates based on actual events. Due to the short duration of the earnout period of two years, increasing or decreasing the risk-adjusted discount rate by 100 basis points would not have a material impact on the fair value measurement of the contingent consideration liability. |
GOODWILL_AND_INTANGIBLE_ASSETS
GOODWILL AND INTANGIBLE ASSETS | 3 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||||||||||||||||||
GOODWILL AND INTANGIBLE ASSETS | GOODWILL AND INTANGIBLE ASSETS | |||||||||||||||||||||||
31-Mar-15 | 31-Dec-14 | |||||||||||||||||||||||
Gross | Accumulated Amortization | Net | Gross | Accumulated Amortization | Net | |||||||||||||||||||
Goodwill | $ | 3,745 | $ | — | $ | 3,745 | $ | 3,745 | $ | — | $ | 3,745 | ||||||||||||
Other indefinite-lived intangibles | $ | 286 | $ | — | $ | 286 | $ | 286 | $ | — | $ | 286 | ||||||||||||
Intangibles assets with finite lives: | ||||||||||||||||||||||||
Customer relationships | 900 | (45 | ) | 855 | 900 | — | 900 | |||||||||||||||||
Patents | 750 | (187 | ) | 563 | 750 | (125 | ) | 625 | ||||||||||||||||
Total | $ | 1,650 | $ | (232 | ) | $ | 1,418 | $ | 1,650 | $ | (125 | ) | $ | 1,525 | ||||||||||
In July 2014, the Company purchased certain patents related to system interconnection and photovoltaic AC module construction. The patents are being amortized over their legal life of 3 years. The customer relationship intangible resulted from the Company’s NPS acquisition and is being amortized on a straight-line basis over its estimated useful life of 5 years. | ||||||||||||||||||||||||
For the three months ended March 31, 2015, amortization expense related to intangible assets was $0.1 million. As of March 31, 2015, estimated future amortization expense related to finite-lived intangible assets was as follows: | ||||||||||||||||||||||||
Year | (In thousands) | |||||||||||||||||||||||
2015 (remaining 9 months) | $ | 323 | ||||||||||||||||||||||
2016 | 430 | |||||||||||||||||||||||
2017 | 305 | |||||||||||||||||||||||
2018 | 180 | |||||||||||||||||||||||
2019 | 180 | |||||||||||||||||||||||
Total | $ | 1,418 | ||||||||||||||||||||||
COMMITMENTS_AND_CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Mar. 31, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES |
Contingencies —The Company is not currently involved in any material legal proceedings. The Company may become involved in various legal proceedings and claims that arise in the ordinary course of business. Such matters are subject to uncertainty and there can be no assurance that such legal proceedings will not have a material adverse effect on its business, results of operations, financial position or cash flows. |
STOCKBASED_COMPENSATION
STOCK-BASED COMPENSATION | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION | |||||||
The Company has adopted certain equity incentive and stock purchase plans as described in the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. | ||||||||
Equity Awards Activity | ||||||||
Stock Options | ||||||||
The following is a summary of stock option activity for the three months ended March 31, 2015 (in thousands, except per share data): | ||||||||
Number of | Weighted- | |||||||
Shares | Average | |||||||
Outstanding | Exercise Price | |||||||
per Share | ||||||||
Outstanding at December 31, 2014 | 8,632 | $ | 4.75 | |||||
Granted | 197 | 12.17 | ||||||
Exercised | (188 | ) | 3.65 | |||||
Canceled | (45 | ) | 9.83 | |||||
Outstanding at March 31, 2015 | 8,596 | 4.92 | ||||||
The intrinsic value of options exercised in the three months ended March 31, 2015 was $1.8 million. As of March 31, 2015, the intrinsic value of options outstanding was $71.7 million based on the closing price of the Company’s stock as of March 31, 2015. | ||||||||
Restricted Stock Units | ||||||||
The following is a summary of restricted stock unit activity for the three months ended March 31, 2015 (in thousands, except per share data): | ||||||||
RSUs | Weighted Average | |||||||
Fair Value per Share at | ||||||||
Grant Date | ||||||||
Outstanding at December 31, 2014 | 1,345 | $ | 8.25 | |||||
Granted | 450 | 13.05 | ||||||
Vested | (172 | ) | 8.04 | |||||
Canceled | — | |||||||
Outstanding at March 31, 2015 | 1,623 | 9.6 | ||||||
The total fair value of restricted stock units that vested in the three months ended March 31, 2015 was $2.5 million. As of March 31, 2015, the intrinsic value of restricted stock units outstanding was $21.4 million based on the closing price of the Company’s stock as of March 31, 2015. | ||||||||
Stock-Based Compensation Expense | ||||||||
Compensation cost for all stock-based awards expected to vest is measured at fair value on the date of grant and recognized ratably over the requisite service period. The following table summarizes the components of total stock-based compensation expense included in the condensed consolidated statements of operations for the periods presented (in thousands): | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Cost of revenues | $ | 264 | $ | 149 | ||||
Research and development | 1,079 | 613 | ||||||
Sales and marketing | 765 | 532 | ||||||
General and administrative | 880 | 719 | ||||||
Total | $ | 2,988 | $ | 2,013 | ||||
The following table summarizes stock-based compensation associated with each type of award for the periods presented (in thousands): | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Stock options and restricted stock units | $ | 2,526 | $ | 1,839 | ||||
Employee stock purchase plan | 462 | 174 | ||||||
Total | $ | 2,988 | $ | 2,013 | ||||
The following table presents the weighted-average grant date fair value of options granted for the periods presented and the assumptions used to estimate those values using a Black-Scholes option pricing model: | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Weighted average grant date fair value | $ | 6.89 | $ | 3.99 | ||||
Expected term (in years) | 4.6 | 4.6 | ||||||
Expected volatility | 71.1 | % | 62.2 | % | ||||
Annual risk-free rate of return | 1.3 | % | 1.4 | % | ||||
Dividend yield | 0 | % | 0 | % | ||||
The fair value of restricted stock units granted is determined based on the price of the Company’s common stock on the date of grant. | ||||||||
As of March 31, 2015, there was approximately $24.4 million of total unrecognized compensation cost related to unvested equity awards expected to be recognized over a weighted-average period of 2.8 years. |
INCOME_TAXES
INCOME TAXES | 3 Months Ended |
Mar. 31, 2015 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES |
The Company has used the discrete tax approach in calculating the tax expense for the three months ended March 31, 2015 and 2014 due to the fact that a relatively small change in the Company’s projected pre-tax net income (loss) could result in a volatile effective tax rate. Under the discrete method, the Company determines its tax (expense) benefit based upon actual results as if the interim period was an annual period. For the three months ended March 31, 2015, the Company recorded a tax provision of $167,000 on a pretax loss of $6.2 million. For the three months ended March 31, 2014, the Company recorded a tax provision of $109,000 on a pretax loss of $6.1 million. The tax provisions recorded were primarily related to income taxes in profitable jurisdictions outside of the U.S. |
NET_LOSS_PER_SHARE
NET LOSS PER SHARE | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Earnings Per Share [Abstract] | ||||||||
NET LOSS PER SHARE | NET LOSS PER SHARE | |||||||
The following table presents the computation of basic and diluted net loss per share (in thousands, except per share data): | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Numerator: | ||||||||
Net loss | $ | (6,320 | ) | $ | (6,236 | ) | ||
Denominator: | ||||||||
Weighted average number of common shares outstanding | 43,950 | 42,205 | ||||||
Net loss per share, basic and diluted | $ | (0.14 | ) | $ | (0.15 | ) | ||
As the Company incurred a net loss for all periods presented, potential dilutive securities from employee stock options, restricted stock units and warrants have been excluded from the diluted net loss per share computations because the effect of including such shares would have been anti-dilutive. The following table sets forth the potentially dilutive securities excluded from the computation of the diluted net loss per share (in thousands): | ||||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Employee stock options | 8,627 | 8,489 | ||||||
Restricted stock units | 1,433 | 732 | ||||||
Warrants to purchase common stock | 111 | 293 | ||||||
Total | 10,171 | 9,514 | ||||||
OVERVIEW_AND_SUMMARY_OF_SIGNIF1
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Consolidation | Basis of Presentation and Consolidation |
The accompanying condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the U.S, or GAAP. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidation. | |
Unaudited Interim Financial Information | Unaudited Interim Financial Information |
These accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, consisting of normal recurring items, considered necessary to present fairly the Company's financial condition, results of operations, comprehensive income (loss) and cash flows for the interim periods indicated. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the operating results for the full year. Certain information and footnote disclosures typically included in annual consolidated financial statements have been condensed or omitted. Accordingly, these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. | |
Use of Estimates | Use of Estimates |
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Significant estimates and assumptions reflected in the financial statements include revenue recognition, inventory valuation and accrued warranty obligations. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ materially from management’s estimates using different assumptions or under different conditions. | |
Income Taxes | The Company has used the discrete tax approach in calculating the tax expense for the three months ended March 31, 2015 and 2014 due to the fact that a relatively small change in the Company’s projected pre-tax net income (loss) could result in a volatile effective tax rate. Under the discrete method, the Company determines its tax (expense) benefit based upon actual results as if the interim period was an annual period. |
INVENTORY_Tables
INVENTORY (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Inventory Disclosure [Abstract] | ||||||||
Summary of Inventory | Inventory as of March 31, 2015 and December 31, 2014 consists of the following (in thousands): | |||||||
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
Raw materials | $ | 4,179 | $ | 3,429 | ||||
Finished goods | 30,567 | 18,161 | ||||||
Total inventory | $ | 34,746 | $ | 21,590 | ||||
WARRANTY_OBLIGATIONS_Tables
WARRANTY OBLIGATIONS (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Product Warranties Disclosures [Abstract] | ||||||||
Summary of Warranty Activities | The Company’s warranty activities during the three months ended March 31, 2015 and 2014 were as follows (in thousands): | |||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Warranty obligations, beginning of period | $ | 33,940 | $ | 30,432 | ||||
Accruals for warranties issued during period | 1,105 | 613 | ||||||
Changes in estimates | 58 | 1,400 | ||||||
Settlements | (1,151 | ) | (1,733 | ) | ||||
Increase due to accretion expense | 161 | 20 | ||||||
Other | 50 | (4 | ) | |||||
Warranty obligations, end of period | $ | 34,163 | $ | 30,728 | ||||
Less current portion | $ | (7,550 | ) | $ | (5,894 | ) | ||
Noncurrent | $ | 26,613 | $ | 24,834 | ||||
FAIR_VALUE_MEASUREMENTS_Tables
FAIR VALUE MEASUREMENTS (Tables) | 3 Months Ended | |||||||||
Mar. 31, 2015 | ||||||||||
Fair Value Disclosures [Abstract] | ||||||||||
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis | The following table presents the Company’s assets and liabilities that were measured at fair value on a recurring basis and its categorization within the fair value hierarchy at March 31, 2015 and December 31, 2014 (in thousands): | |||||||||
Fair Value | March 31, | December 31, | ||||||||
Hierarchy | 2015 | 2014 | ||||||||
Assets: | ||||||||||
Foreign currency forward contracts | Level 2 | $ | 59 | $ | 76 | |||||
Liabilities: | ||||||||||
Foreign currency forward contracts | Level 2 | $ | — | $ | — | |||||
Warranty obligations | Level 3 | 4,783 | 3,562 | |||||||
Contingent consideration | Level 3 | 2,404 | 2,300 | |||||||
Schedule of Changes in Nonfinancial Liabilities Related to Warrant Obligations Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs | The following table provides information regarding changes in nonfinancial liabilities related to the Company’s warranty obligations measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the periods indicated (in thousands): | |||||||||
Three Months Ended | ||||||||||
March 31, | ||||||||||
2015 | 2014 | |||||||||
Balance at beginning of period | $ | 3,562 | $ | — | ||||||
Accruals for warranties issued during period | 1,047 | 571 | ||||||||
Changes in estimates | — | — | ||||||||
Settlements | (36 | ) | — | |||||||
Increase due to accretion expense | 161 | 20 | ||||||||
Other | 49 | (4 | ) | |||||||
Balance at end of period | $ | 4,783 | $ | 587 | ||||||
Summary of Changes in Financial Liabilities Related to Contingent Consideration Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs | The following table provides information regarding changes in financial liabilities related to the contingent consideration liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2015 (in thousands): | |||||||||
Balance—December 31, 2014 | $ | 2,300 | ||||||||
Revaluations | 104 | |||||||||
Balance—March 31, 2015 | $ | 2,404 | ||||||||
Summary of Significant Unobservable Inputs used in the Fair Value Measurement of Liabilities Designated as Level 3 | As of March 31, 2015, the significant unobservable inputs used in the fair value measurement of the Company’s liabilities designated as Level 3 are as follows: | |||||||||
Item Measured at Fair Value | Valuation Technique | Description of Significant Unobservable Input | Percent Used | |||||||
(Weighted-Average) | ||||||||||
Warranty obligations for microinverters sold since January 1, 2014 | Discounted cash flows | Profit element and risk premium | 17% | |||||||
Credit-adjusted risk-free rate | 18% | |||||||||
Contingent consideration liability | Probability-weighted discounted cash flows | Risk-adjusted discount rate | 18% |
GOODWILL_AND_INTANGIBLE_ASSETS1
GOODWILL AND INTANGIBLE ASSETS (Tables) | 3 Months Ended | |||||||||||||||||||||||
Mar. 31, 2015 | ||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||||||||||||||||||||||
Schedule of Goodwill and Intangible Assets | ||||||||||||||||||||||||
31-Mar-15 | 31-Dec-14 | |||||||||||||||||||||||
Gross | Accumulated Amortization | Net | Gross | Accumulated Amortization | Net | |||||||||||||||||||
Goodwill | $ | 3,745 | $ | — | $ | 3,745 | $ | 3,745 | $ | — | $ | 3,745 | ||||||||||||
Other indefinite-lived intangibles | $ | 286 | $ | — | $ | 286 | $ | 286 | $ | — | $ | 286 | ||||||||||||
Intangibles assets with finite lives: | ||||||||||||||||||||||||
Customer relationships | 900 | (45 | ) | 855 | 900 | — | 900 | |||||||||||||||||
Patents | 750 | (187 | ) | 563 | 750 | (125 | ) | 625 | ||||||||||||||||
Total | $ | 1,650 | $ | (232 | ) | $ | 1,418 | $ | 1,650 | $ | (125 | ) | $ | 1,525 | ||||||||||
Schedule of Estimated Future Amortization Expense Related to Finite-Lived Intangible Assets | For the three months ended March 31, 2015, amortization expense related to intangible assets was $0.1 million. As of March 31, 2015, estimated future amortization expense related to finite-lived intangible assets was as follows: | |||||||||||||||||||||||
Year | (In thousands) | |||||||||||||||||||||||
2015 (remaining 9 months) | $ | 323 | ||||||||||||||||||||||
2016 | 430 | |||||||||||||||||||||||
2017 | 305 | |||||||||||||||||||||||
2018 | 180 | |||||||||||||||||||||||
2019 | 180 | |||||||||||||||||||||||
Total | $ | 1,418 | ||||||||||||||||||||||
STOCKBASED_COMPENSATION_Tables
STOCK-BASED COMPENSATION (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||
Summary of Stock Option Activity | The following is a summary of stock option activity for the three months ended March 31, 2015 (in thousands, except per share data): | |||||||
Number of | Weighted- | |||||||
Shares | Average | |||||||
Outstanding | Exercise Price | |||||||
per Share | ||||||||
Outstanding at December 31, 2014 | 8,632 | $ | 4.75 | |||||
Granted | 197 | 12.17 | ||||||
Exercised | (188 | ) | 3.65 | |||||
Canceled | (45 | ) | 9.83 | |||||
Outstanding at March 31, 2015 | 8,596 | 4.92 | ||||||
Summary of Restricted Stock Unit Activity | The following is a summary of restricted stock unit activity for the three months ended March 31, 2015 (in thousands, except per share data): | |||||||
RSUs | Weighted Average | |||||||
Fair Value per Share at | ||||||||
Grant Date | ||||||||
Outstanding at December 31, 2014 | 1,345 | $ | 8.25 | |||||
Granted | 450 | 13.05 | ||||||
Vested | (172 | ) | 8.04 | |||||
Canceled | — | |||||||
Outstanding at March 31, 2015 | 1,623 | 9.6 | ||||||
Summary of the Components of Total Stock-Based Compensation Expense | The following table summarizes the components of total stock-based compensation expense included in the condensed consolidated statements of operations for the periods presented (in thousands): | |||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Cost of revenues | $ | 264 | $ | 149 | ||||
Research and development | 1,079 | 613 | ||||||
Sales and marketing | 765 | 532 | ||||||
General and administrative | 880 | 719 | ||||||
Total | $ | 2,988 | $ | 2,013 | ||||
Summary of Stock-Based Compensation Associated with Each Type of Award | The following table summarizes stock-based compensation associated with each type of award for the periods presented (in thousands): | |||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Stock options and restricted stock units | $ | 2,526 | $ | 1,839 | ||||
Employee stock purchase plan | 462 | 174 | ||||||
Total | $ | 2,988 | $ | 2,013 | ||||
Summary of the Weighted-Average Grant Date Fair Value of Options Granted | The following table presents the weighted-average grant date fair value of options granted for the periods presented and the assumptions used to estimate those values using a Black-Scholes option pricing model: | |||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Weighted average grant date fair value | $ | 6.89 | $ | 3.99 | ||||
Expected term (in years) | 4.6 | 4.6 | ||||||
Expected volatility | 71.1 | % | 62.2 | % | ||||
Annual risk-free rate of return | 1.3 | % | 1.4 | % | ||||
Dividend yield | 0 | % | 0 | % |
NET_LOSS_PER_SHARE_Tables
NET LOSS PER SHARE (Tables) | 3 Months Ended | |||||||
Mar. 31, 2015 | ||||||||
Earnings Per Share [Abstract] | ||||||||
Schedule of Computation of Basic and Diluted Net Loss Per Share | The following table presents the computation of basic and diluted net loss per share (in thousands, except per share data): | |||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Numerator: | ||||||||
Net loss | $ | (6,320 | ) | $ | (6,236 | ) | ||
Denominator: | ||||||||
Weighted average number of common shares outstanding | 43,950 | 42,205 | ||||||
Net loss per share, basic and diluted | $ | (0.14 | ) | $ | (0.15 | ) | ||
Schedule of Potentially Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share | The following table sets forth the potentially dilutive securities excluded from the computation of the diluted net loss per share (in thousands): | |||||||
Three Months Ended | ||||||||
March 31, | ||||||||
2015 | 2014 | |||||||
Employee stock options | 8,627 | 8,489 | ||||||
Restricted stock units | 1,433 | 732 | ||||||
Warrants to purchase common stock | 111 | 293 | ||||||
Total | 10,171 | 9,514 | ||||||
INVENTORY_Summary_of_Inventory
INVENTORY - Summary of Inventory (Details) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Thousands, unless otherwise specified | ||
Schedule of inventory | ||
Raw materials | $4,179 | $3,429 |
Finished goods | 30,567 | 18,161 |
Total inventory | $34,746 | $21,590 |
WARRANTY_OBLIGATIONS_Summary_o
WARRANTY OBLIGATIONS - Summary of Warranty Activities (Details) (USD $) | 3 Months Ended | ||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 |
Changes in the Company's product warranty liability | |||
Warranty obligations, beginning of period | $33,940 | $30,432 | |
Accruals for warranties issued during period | 1,105 | 613 | |
Changes in estimates | 58 | 1,400 | |
Settlements | -1,151 | -1,733 | |
Increase due to accretion expense | 161 | 20 | |
Other | 50 | -4 | |
Warranty obligations, end of period | 34,163 | 30,728 | |
Less current portion | -7,550 | -5,894 | -7,607 |
Noncurrent | $26,613 | $24,834 | $26,333 |
WARRANTY_OBLIGATIONS_Narrative
WARRANTY OBLIGATIONS - Narrative (Details) (USD $) | 3 Months Ended | |||
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 |
Product Warranty Liability [Line Items] | ||||
Changes in warranty estimates | $58 | $1,400 | ||
Warranty obligations | 34,163 | 30,728 | 33,940 | 30,432 |
Recurring | Warranty obligations for microinverters sold since January 1, 2014 | Level 3 | ||||
Product Warranty Liability [Line Items] | ||||
Fair value liabilities | $4,783 | $587 | $3,562 | $0 |
FAIR_VALUE_MEASUREMENTS_Schedu
FAIR VALUE MEASUREMENTS - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) (Recurring, USD $) | Mar. 31, 2015 | Dec. 31, 2014 | Mar. 31, 2014 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | ||||
Level 2 | ||||
Assets: | ||||
Foreign currency forward contracts | $59 | $76 | ||
Liabilities: | ||||
Foreign currency forward contracts | 0 | 0 | ||
Warranty obligations | Level 3 | ||||
Liabilities: | ||||
Fair value liabilities | 4,783 | 3,562 | 587 | 0 |
Contingent consideration | Level 3 | ||||
Liabilities: | ||||
Fair value liabilities | $2,404 | $2,300 |
FAIR_VALUE_MEASUREMENTS_Narrat
FAIR VALUE MEASUREMENTS - Narrative (Details) (USD $) | 3 Months Ended | ||
Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014 | |
Derivative [Line Items] | |||
Contingent consideration earnout period | 2 years | ||
Not designated as hedging instrument | Foreign exchange forward | |||
Derivative [Line Items] | |||
Notional amount of foreign currency | $1,300,000 | $1,500,000 | |
Net gain on foreign currency | 148,000 | 50,000 | |
Discounted cash flows | Recurring | Level 3 | Contingent consideration | |||
Derivative [Line Items] | |||
Decrease to fair value measurement as a result of 100 basis point increase | 200,000 | ||
Increase to fair value measurement as a result of 100 basis point decrease | 200,000 | ||
Next Phase Solar, Inc. | |||
Derivative [Line Items] | |||
Number of contingent payments | 2 | ||
Contingent payment, low range of undiscounted amounts | 0 | ||
Contingent payment, high range of undiscounted amounts | $2,800,000 |
FAIR_VALUE_MEASUREMENTS_Schedu1
FAIR VALUE MEASUREMENTS - Schedule of Changes in Nonfinancial Liabilities Related to Warrant Obligations Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Details) (Level 3, Recurring, Warranty obligations, USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Level 3 | Recurring | Warranty obligations | ||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance at beginning of period | $3,562 | $0 |
Accruals for warranties issued during period | 1,047 | 571 |
Changes in estimates | 0 | 0 |
Settlements | -36 | 0 |
Increase due to accretion expense | 161 | 20 |
Other | 49 | -4 |
Balance at end of period | $4,783 | $587 |
FAIR_VALUE_MEASUREMENTS_Summar
FAIR VALUE MEASUREMENTS - Summary of Changes in Financial Liabilities Related to Contingent Consideration Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Details) (Next Phase Solar, Inc., Contingent consideration, Recurring, Level 3, USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Mar. 31, 2015 |
Next Phase Solar, Inc. | Contingent consideration | Recurring | Level 3 | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance at beginning of period | $2,300 |
Revaluations | 104 |
Balance at end of period | $2,404 |
FAIR_VALUE_MEASUREMENTS_Summar1
FAIR VALUE MEASUREMENTS - Summary of Significant Unobservable Inputs used in the Fair Value Measurement of Liabilities Designated as Level 3 (Details) (Discounted cash flows, Recurring, Level 3) | 3 Months Ended |
Mar. 31, 2015 | |
Warranty obligations for microinverters sold since January 1, 2014 | |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | |
Profit element and risk premium | 17.00% |
Credit-adjusted risk-free rate | 18.00% |
Contingent consideration liability | |
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items] | |
Risk-adjusted discount rate | 18.00% |
GOODWILL_AND_INTANGIBLE_ASSETS2
GOODWILL AND INTANGIBLE ASSETS - Schedule of Goodwill and Intangible Assets (Details) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Thousands, unless otherwise specified | ||
Finite-Lived Intangible Assets [Line Items] | ||
Goodwill, gross | $3,745 | $3,745 |
Goodwill | 3,745 | 3,745 |
Other indefinite-lived intangibles | 286 | 286 |
Intangibles assets with finite lives: | ||
Intangibles assets with finite lives, gross | 1,650 | 1,650 |
Intangibles assets with finite lives, accumulated amortization | -232 | -125 |
Total | 1,418 | 1,525 |
Customer relationships | ||
Intangibles assets with finite lives: | ||
Intangibles assets with finite lives, gross | 900 | 900 |
Intangibles assets with finite lives, accumulated amortization | -45 | 0 |
Total | 855 | 900 |
Patents | ||
Intangibles assets with finite lives: | ||
Intangibles assets with finite lives, gross | 750 | 750 |
Intangibles assets with finite lives, accumulated amortization | -187 | -125 |
Total | $563 | $625 |
GOODWILL_AND_INTANGIBLE_ASSETS3
GOODWILL AND INTANGIBLE ASSETS - Narrative (Details) (USD $) | 3 Months Ended | 1 Months Ended |
In Millions, unless otherwise specified | Mar. 31, 2015 | Jul. 31, 2014 |
Finite-Lived Intangible Assets [Line Items] | ||
Amortization expense related to intangible assets | $0.10 | |
Patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Useful life | 3 years | |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Useful life | 5 years |
GOODWILL_AND_INTANGIBLE_ASSETS4
GOODWILL AND INTANGIBLE ASSETS - Schedule of Estimated Future Amortization Expense Related to Finite-Lived Intangible Assets (Details) (USD $) | Mar. 31, 2015 | Dec. 31, 2014 |
In Thousands, unless otherwise specified | ||
Goodwill and Intangible Assets Disclosure [Abstract] | ||
2015 (remaining 9 months) | $323 | |
2016 | 430 | |
2017 | 305 | |
2018 | 180 | |
2019 | 180 | |
Total | $1,418 | $1,525 |
STOCKBASED_COMPENSATION_Summar
STOCK-BASED COMPENSATION - Summary of Stock Option Activity (Details) (USD $) | 3 Months Ended |
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2015 |
Number of Shares Outstanding | |
Outstanding, beginning balance (in shares) | 8,632 |
Granted (in shares) | 197 |
Exercised (in shares) | -188 |
Canceled (in shares) | -45 |
Outstanding, ending balance (in shares) | 8,596 |
Weighted- Average Exercise Price per Share | |
Outstanding, beginning balance (in usd per share) | $4.75 |
Granted (in usd per share) | $12.17 |
Exercised (in usd per share) | $3.65 |
Canceled (in usd per share) | $9.83 |
Outstanding, ending balance (in usd per share) | $4.92 |
STOCKBASED_COMPENSATION_Narrat
STOCK-BASED COMPENSATION - Narrative (Details) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 31, 2015 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Intrinsic value of options exercised during period | $1.80 |
Intrinsic value of options outstanding | 71.7 |
Total unrecognized compensation cost | 24.4 |
Weighted-average recognition period for unrecognized compensation cost | 2 years 9 months 6 days |
Restricted stock | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Fair value of stock vested during period | 2.5 |
Intrinsic value of restricted stock units outstanding | $21.40 |
STOCKBASED_COMPENSATION_Summar1
STOCK-BASED COMPENSATION - Summary of Restricted Stock Unit Activity (Details) (Restricted stock units, USD $) | 3 Months Ended |
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2015 |
Restricted stock units | |
RSUs | |
Outstanding, beginning balance (in shares) | 1,345 |
Granted (in shares) | 450 |
Vested (in shares) | -172 |
Canceled (in shares) | 0 |
Outstanding, ending balance (in shares) | 1,623 |
Weighted Average Fair Value per Share at Grant Date | |
Outstanding, beginning balance (in usd per share) | $8.25 |
Granted (in usd per share) | $13.05 |
Vested (in usd per share) | $8.04 |
Canceled (in usd per share) | |
Outstanding, ending balance (in usd per share) | $9.60 |
STOCKBASED_COMPENSATION_Summar2
STOCK-BASED COMPENSATION - Summary of the Components of Total Stock-Based Compensation Expense (Details) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Allocation of Stock-based Compensation Expense Included in the Consolidated Statement of Operations [Abstract] | ||
Total stock-based compensation expense | $2,988 | $2,013 |
Cost of revenues | ||
Allocation of Stock-based Compensation Expense Included in the Consolidated Statement of Operations [Abstract] | ||
Total stock-based compensation expense | 264 | 149 |
Research and development | ||
Allocation of Stock-based Compensation Expense Included in the Consolidated Statement of Operations [Abstract] | ||
Total stock-based compensation expense | 1,079 | 613 |
Sales and marketing | ||
Allocation of Stock-based Compensation Expense Included in the Consolidated Statement of Operations [Abstract] | ||
Total stock-based compensation expense | 765 | 532 |
General and administrative | ||
Allocation of Stock-based Compensation Expense Included in the Consolidated Statement of Operations [Abstract] | ||
Total stock-based compensation expense | $880 | $719 |
STOCKBASED_COMPENSATION_Summar3
STOCK-BASED COMPENSATION - Summary of Stock-Based Compensation Associated with Each Type of Award (Details) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $2,988 | $2,013 |
Stock options and restricted stock units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 2,526 | 1,839 |
Employee stock purchase plan | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $462 | $174 |
STOCKBASED_COMPENSATION_Summar4
STOCK-BASED COMPENSATION - Summary of the Weighted-Average Grant Date Fair Value of Options Granted (Details) (Stock options, USD $) | 3 Months Ended | |
Mar. 31, 2015 | Mar. 31, 2014 | |
Stock options | ||
The fair value of each option granted during the periods | ||
Weighted average grant date fair value (in usd per share) | $6.89 | $3.99 |
Expected term (in years) | 4 years 7 months 6 days | 4 years 7 months 6 days |
Expected volatility | 71.10% | 62.20% |
Annual risk-free rate of return | 1.30% | 1.40% |
Dividend yield | 0.00% | 0.00% |
INCOME_TAXES_Narrative_Details
INCOME TAXES - Narrative (Details) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Income Tax Disclosure [Abstract] | ||
Provision for income taxes | $167 | $109 |
Loss before income taxes | $6,153 | $6,127 |
NET_LOSS_PER_SHARE_Schedule_of
NET LOSS PER SHARE - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Numerator: | ||
Net loss | ($6,320) | ($6,236) |
Denominator: | ||
Weighted average number of common shares outstanding (in shares) | 43,950 | 42,205 |
Net loss per share, basic and diluted (in usd per share) | ($0.14) | ($0.15) |
NET_LOSS_PER_SHARE_Schedule_of1
NET LOSS PER SHARE - Schedule of Potentially Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details) | 3 Months Ended | |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
The potential common shares outstanding that were excluded from the computation of diluted net loss per share attributable to common stockholders | ||
Total (in shares) | 10,171 | 9,514 |
Employee stock options | ||
The potential common shares outstanding that were excluded from the computation of diluted net loss per share attributable to common stockholders | ||
Total (in shares) | 8,627 | 8,489 |
Restricted stock units | ||
The potential common shares outstanding that were excluded from the computation of diluted net loss per share attributable to common stockholders | ||
Total (in shares) | 1,433 | 732 |
Warrants to purchase common stock | ||
The potential common shares outstanding that were excluded from the computation of diluted net loss per share attributable to common stockholders | ||
Total (in shares) | 111 | 293 |